Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Cellular and Molecular Immunology

Volumn 17, Issue 5, 2020, Pages 533-535

  Zheng, Meijuan ^a   Gao, Yong ^a   Wang, Gang ^a   Song, Guobin ^a   Liu, Siyu ^a   Sun, Dandan ^a   Xu, Yuanhong ^a   Tian, Zhigang ^b,c  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHLOROQUINE; D DIMER; GAMMA INTERFERON; GRANZYME B; HEMOGLOBIN; INTERLEUKIN 2; LACTATE DEHYDROGENASE; LOPINAVIR PLUS RITONAVIR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR NKG2A; TUMOR NECROSIS FACTOR; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CD8 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHILD; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; COUGHING; CYTOTOXIC LYMPHOCYTE; DISEASE SEVERITY; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LYMPHOCYTE FUNCTION; LYMPHOCYTE PERCENTAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATURAL KILLER CELL; NEUTROPHIL COUNT; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SPUTUM; STAINING; UPREGULATION; BETACORONAVIRUS; CORONAVIRUS INFECTION; HEPATITIS C; PANDEMIC; VIRUS PNEUMONIA;

ANTIVIRAL AGENTS; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; HEPATITIS C; HUMANS; KILLER CELLS, NATURAL; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85082754260     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/s41423-020-0402-2     Document Type: Letter

References (10)

1. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
2. Zhang, C. et al. NKG2A is a NK cell exhaustion checkpoint for HCV persistence. Nat. Commun. 10, 1507 (2019).
3. Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
4. Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020).
5. Li, F. et al. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Gastroenterology 144, 392–401 (2013).
6. Andre, P. et al. Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells. Cell 175, 1731–1743 (2018).
7. Barathan, M. et al. Viral persistence and chronicity in hepatitis C virus infection: role of T-cell apoptosis, senescence and exhaustion. Cells 7, 165 (2018).
8. Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682–687 (2006).
9. Zhang, Q. et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat. Immunol. 19, 723–732 (2018).
10. Haanen, J. B. & Cerundolo, V. NKG2A, a new kid on the immune checkpoint block. Cell 175, 1720–1722 (2018).